1 Min Read
Dec 1 (Reuters) - Azurrx Biopharma Inc
* Azurrx Biopharma Inc - expect to file an investigational new drug application for AZX1101 in 2017 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.